Together, these results demonstrate that in addition to the increased tumor-initiating potential of ER-positive Brca1-proficient tumor cells, estrogen enhances the number of Brca1-deficient CSCs and promotes ER-negative basal-like tumor initiation and progression. Here, BRCA1 is linked to neoplasm.